KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 108 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,679,952 | +67.0% | 278,292 | +56.1% | 0.75% | +34.6% |
| Q2 2023 | $1,604,628 | -2.0% | 178,292 | -14.4% | 0.56% | +3.7% |
| Q1 2023 | $1,637,175 | +28.6% | 208,292 | +10.6% | 0.54% | +8.2% |
| Q4 2022 | $1,272,854 | -9.0% | 188,292 | +95.5% | 0.50% | +27.9% |
| Q3 2022 | $1,398,000 | +16.7% | 96,318 | +92.6% | 0.39% | -9.1% |
| Q2 2021 | $1,198,000 | -53.4% | 50,000 | -50.0% | 0.43% | -50.8% |
| Q1 2021 | $2,569,000 | +200.5% | 100,000 | +122.2% | 0.87% | +92.5% |
| Q4 2020 | $855,000 | – | 45,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |